视黄酸依赖Fas/RARa融合基因转导靶细胞启动的细胞自杀效应研究

基本信息
批准号:39970321
项目类别:面上项目
资助金额:12.00
负责人:糜漫天
学科分类:
依托单位:中国人民解放军第三军医大学
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:糜漫天,徐访潜,黄继明,杨志祥,周东明,郎海滨,韦娜,袁家林
关键词:
视黄酸Fas融合基因细胞自杀
结项摘要

In this paper, we constructed a novel expression vector of fusion gene Fas/RAR alpha containing RARE-TK promoter and reporter gene eGFP controlled by ATRA and observed the effect of apoptosis initiated by fusion protein Fas/RAR alpha after transfection to HL-60 and MCF-7 malignant cells. The results and conclusions are summarized as follows: 1) The reporter gene plasmid containing RARE (pRARE3-TK-eGFP) was transfected into HL-60 cells. After treatment with ATRA, the expression of eGFP was detected by fluorescence microscopy and RT-PCR. Treatment of transfected HL-60 cells with RA for scheduled times resulted in obvious increase of eGFP in RA dependent manner. These findings suggested that RA is able to induce the expression of exogenous gene under RARE-TK promoter. 2) The fusion gene vector (pRARE-Fas/RAR alpha) containing RARE-TK promoter and eGFP was constructed and transfected to HL-60 and MCF-7 cells. Transfected cells were treated with RA for 24h, 48h, and 72h respectively, as compared with nontransfected ones treated with RA at the same time. The expression of reporter gene (fusion gene) in pRARE-Fas/RAR alpha transfected cells stimulated with RA was higher than that in control group. And it was found that the fusion protein Fas/RAR alpha was mainly located in cell membrane. 3) The proliferation capacity was decreased, the apoptotic rate and the DNA fragmentation rate were increased in cells treated by RA. The DNA ladder was detectable in RA-treated cells. The morphological apoptosis changes were observed by transmission electron microscopy and TUNEL detection. These changes were more obviously in pRARE-Fas/RAR alpha transfected cells than nontransfected cells. Our study demonstrated that RA and the product of exogenous fusion gene induced by RA could cooperate in inhibition of cell growth and inducing apoptosis.4) The expressions of caspase-8 and caspase-3 genes were increased in tumor cells treated with RA. The expression of active subunit protein of caspase-3 was increased in HL-60 cells treated with RA. These changes were more obvious in transfected cells than nontransfected cells. Our study suggested that up-regulated expression and activity of several caspases may be play a key role in RA and fusion gene inducing apoptosis..The results above are helpful to find the optimal strategies to overcome the resistance to RA and decrease ill effects in clinical use of RA. .

通过构建含Fas抗原“死亡区”和视黄酸核受体RAR配体结合区的融合基因表达载体,使该基因表达受控于视黄酸反应元件(RARE)相连的TK启动子,将Fas/RARa融合基因转导入耐药早幼粒白血病细胞内,进而用视黄酸启动配体依赖细胞自杀机制,清除诱导分化治疗耐药的抗性细胞。该项目在于采用一全新的基因治疗策略有效解决肿瘤诱导分化治疗中的耐药问题。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
2

基于多模态信息特征融合的犯罪预测算法研究

基于多模态信息特征融合的犯罪预测算法研究

DOI:
发表时间:2018
3

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
4

当归补血汤促进异体移植的肌卫星细胞存活

当归补血汤促进异体移植的肌卫星细胞存活

DOI:
发表时间:2016
5

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

DOI:10.13692/ j.cnki.gywsy z yb.2016.03.002
发表时间:2016

糜漫天的其他基金

批准号:81673157
批准年份:2016
资助金额:60.00
项目类别:面上项目
批准号:81172670
批准年份:2011
资助金额:50.00
项目类别:面上项目
批准号:30671754
批准年份:2006
资助金额:30.00
项目类别:面上项目
批准号:30271128
批准年份:2002
资助金额:21.00
项目类别:面上项目
批准号:30371217
批准年份:2003
资助金额:21.00
项目类别:面上项目
批准号:39770303
批准年份:1997
资助金额:12.00
项目类别:面上项目
批准号:81072288
批准年份:2010
资助金额:36.00
项目类别:面上项目
批准号:81470562
批准年份:2014
资助金额:80.00
项目类别:面上项目
批准号:39570296
批准年份:1995
资助金额:8.00
项目类别:面上项目

相似国自然基金

1

骨钙启动、复制型腺病毒载体转导自杀基因治疗骨肉瘤

批准号:39970289
批准年份:1999
负责人:朱全胜
学科分类:H1819
资助金额:13.00
项目类别:面上项目
2

肺癌自杀基因靶向转导载体构建研究

批准号:30471997
批准年份:2004
负责人:何建行
学科分类:H1819
资助金额:21.00
项目类别:面上项目
3

高效靶向调控Fas基因转导联合Fas抗体治疗人卵巢癌的实验研究

批准号:30571945
批准年份:2005
负责人:沈铿
学科分类:H1819
资助金额:25.00
项目类别:面上项目
4

视黄酸依赖反义CyclinD1诱导白血病细胞分化研究

批准号:30070328
批准年份:2000
负责人:杨志祥
学科分类:H0809
资助金额:16.00
项目类别:面上项目